1-benzyl-3-(4-methoxy-benzenesulfonyl)-6-oxo-hexahydro-pyrimidine-4-carboxylic acid hydroxyamide

This compound is a synthetic small molecule with the chemical formula C19H21N3O6S and a molecular weight of approximately 419.45 g/mol[1][2][4]. It features several notable functional groups, including a sulfonyl group, hydroxamic acid moiety, and ketone within a hexahydropyrimidine ring structure[3][4]. Compounds containing hydroxamic acids are often studied as enzyme inhibitors—particularly for their potential anti-cancer, anti-inflammatory, or antibacterial activities—though there is no evidence this specific molecule has been clinically developed or approved for any indication[1][2][3]. No clinical trials or regulatory approvals have been reported for this drug as of June 2025[2].

Other names

1-benzyl-3-(4-methoxyphenyl)sulfonyl-6-oxo-hexahydropyrimidine-4-carbohydroxamic acid(4R)-1-benzyl-N-hydroxy-3-(4-methoxybenzenesulfonyl)-6-oxohexahydro-pyrimidinecarboxamideAHIBBHDESCARBOXY-NOR-N(ω)-HYDROXY-L‑ARGININE